C Estrach, S Mpofu, R J Moots. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » AdultAntibodies, Monoclonal/administration & dosageAntirheumatic Agents/administration & dosageBehcet Syndrome/therapyEtanerceptFemaleHumansImmunoglobulin G/administration & dosageInfliximabReceptors, Tumor Necrosis Factor/administration & dosageTreatment Failure
Substances: See more » Antibodies, MonoclonalAntirheumatic AgentsImmunoglobulin GReceptors, Tumor Necrosis FactorInfliximabEtanercept
Year: 2002 PMID: 12364656
Source DB: PubMed Journal: Rheumatology (Oxford) ISSN: 1462-0324 Impact factor: 7.580